Gross Margin

Facing market headwinds, tea supplier Oriental Rise makes a bold move to acquire a major producer, aiming to secure its supply chain and boost quality.

Profound Medical raises over $42M to advance its AI-powered, incision-free therapies for cancer and other diseases, signaling strong investor confidence.

Customers face a 3% interim water rate hike in January as regulators review a plan that could see bills climb over 30% to fund infrastructure.

Riding a wave of record revenue and a favorable reimbursement outlook, iRhythm's upcoming JPM presentation is a key test for its 2026 growth strategy.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A new report details how interconnected apps, wearables, and AI are creating a 'Human Performance Economy' that extends far beyond the gym's walls.

With promising survival data and a pivotal Phase 3 trial underway, Imunon's localized immunotherapy could finally change the game for ovarian cancer.

With a new HQ and $2M in contracts, Taoping is leveraging AI and government policy to modernize China's aging elevators, but faces investor scrutiny.

Ethical food leader Vital Farms heads to the ICR Conference with record profits and a $2B goal, ready to prove its model can win against new competition.

Fresh off a volatile IPO, Malaysian hotpot chain CCH Holdings plans a massive 2026 expansion. Can this small-cap company conquer the U.S. and Africa?

iQSTEL caps a transformational year with a NASDAQ uplist, record revenue, and a strategic pivot to Fintech and Cybersecurity, eyeing a $1B future.

DHT Holdings sells two older tankers for $101.6M, securing a major cash injection. The move highlights a strategy of fleet renewal and shareholder value.

Indonesia's Mowilex marks seven years of verified carbon neutrality, pivoting from certificates to permanent infrastructure with major solar power investments.

With a strong debut on the Hong Kong Stock Exchange, USAS Building System highlights growing investor faith in prefabricated industrial construction.

Biomaterials firm Bolt Projects posts huge revenue gains and raises 2026 guidance, but a looming Nasdaq delisting threat casts a shadow on its future.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Chinese insurtech Huize is cutting back on financial reports to focus on strategy, but its latest data shows a complex picture of soaring premiums and slowing new user growth.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.